In vivo, stable ERα expression has been reported in patient-derived xenograft (PDX) models, especially in tumor cells introduced via intraductal transplantations8,9 and these findings have suggested a strong microenvironment-dependent dynamic component in the regulation of ERα expression. The gene discussed is ESR1; the disease is neoplasm.